Iovance Biotherapeutics to Present at Upcoming Investor and Medical Conferences
Iovance Biotherapeutics, Inc. (IOVA)
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
iovance.com
Company Research
Source: GlobeNewswire
SAN CARLOS, Calif., Feb. 01, 2019 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that the company will participate and present at the following upcoming conferences: 5th Annual Immuno-Oncology 360° conference in New York, February 6-8, 2019Presenter: Maria Fardis, Ph.D., President and Chief Executive OfficerSession: Next Generation Cell Therapy PlenaryTitle: Advancing the Development of Tumor Infiltrating Lymphocytes for Solid TumorsLocation: Crowne Plaza Times SquareDate/Time: February 8 at 11:10 a.m. EST Guggenheim Healthcare Talks Idea Forum Oncology Day in New York on February 14, 2019Date/Time: Thursday, February 14, 2019 at 3:00 p.m. ESTLocation: The St. Regis New York HotelWebcast: A live and archived audio webcast of the presentation will be available in the Investors section at www.iovance.com. ASCO-SITC Clinical Immu
Show less
Read more
Impact Snapshot
Event Time:
IOVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IOVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IOVA alerts
High impacting Iovance Biotherapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
IOVA
News
- Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual MeetingGlobeNewswire
- These Biotech Stocks Could Soar 120% and 295%, According to Wall Street [Yahoo! Finance]Yahoo! Finance
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)GlobeNewswire
- Is Iovance Biotherapeutics Stock a Buy Now? [Yahoo! Finance]Yahoo! Finance
- Market Sentiment Around Loss-Making Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) [Yahoo! Finance]Yahoo! Finance
IOVA
Earnings
- 2/28/24 - Miss
IOVA
Sec Filings
- 4/17/24 - Form 4
- 4/17/24 - Form 4
- 4/17/24 - Form 4
- IOVA's page on the SEC website